Does Fanapt Cause Heart-Related Side Effects?
Yes, Fanapt (iloperidone), an atypical antipsychotic for schizophrenia, carries risks of several heart-related side effects. The prescribing information lists QT prolongation as a key concern, which can lead to torsades de pointes and sudden cardiac death. Orthostatic hypotension, tachycardia, and palpitations also occur.[1][2]
How Common Are These Effects?
In clinical trials, QT interval prolongation happened in about 9% of patients on Fanapt versus 3-5% on placebo, with changes over 60 ms in 2-4% of cases. Tachycardia affected up to 12%, and orthostatic hypotension up to 4%. Serious events like ventricular arrhythmias are rare but documented in post-marketing reports.[1][3]
What Increases the Risk?
Risk rises with higher doses (24 mg/day doubles QT effects compared to 12 mg/day), concurrent use of QT-prolonging drugs (e.g., certain antibiotics, antidepressants), electrolyte imbalances (low potassium/magnesium), congenital long QT syndrome, or heart disease history. Baseline ECG is recommended before starting.[1][2]
What Do Doctors Monitor?
Guidelines advise ECGs before treatment, after dose increases, and if symptoms like dizziness or fainting appear. Blood pressure checks help spot hypotension. Avoid in patients with recent heart attacks or uncompensated failure.[1]
Patient Experiences and Warnings
Users report palpitations, rapid heartbeat, and rare fainting on forums and FDA reports. Black box warnings cover increased mortality in elderly dementia patients (often cardiac-related) and metabolic effects indirectly straining the heart, like weight gain.[2][4]
[1]: Fanapt Prescribing Information (FDA)
[2]: Drugs.com - Fanapt Side Effects
[3]: RxList - Fanapt
[4]: FDA Adverse Event Reporting System (FAERS) Summary